Literature DB >> 23990662

Role of the hydrophobic and charged residues in the 218-226 region of apoA-I in the biogenesis of HDL.

Panagiotis Fotakis1, Andreas K Kateifides, Christina Gkolfinopoulou, Dimitra Georgiadou, Melissa Beck, Katharina Gründler, Angeliki Chroni, Efstratios Stratikos, Dimitris Kardassis, Vassilis I Zannis.   

Abstract

We investigated the significance of hydrophobic and charged residues 218-226 on the structure and functions of apoA-I and their contribution to the biogenesis of HDL. Adenovirus-mediated gene transfer of apoA-I[L218A/L219A/V221A/L222A] in apoA-I⁻/⁻ mice decreased plasma cholesterol and apoA-I levels to 15% of wild-type (WT) control mice and generated pre-β- and α4-HDL particles. In apoA-I⁻/⁻ × apoE⁻/⁻ mice, the same mutant formed few discoidal and pre-β-HDL particles that could not be converted to mature α-HDL particles by excess LCAT. Expression of the apoA-I[E223A/K226A] mutant in apoA-I⁻/⁻ mice caused lesser but discrete alterations in the HDL phenotype. The apoA-I[218-222] and apoA-I[E223A/K226A] mutants had 20% and normal capacity, respectively, to promote ABCA1-mediated cholesterol efflux. Both mutants had ∼65% of normal capacity to activate LCAT in vitro. Biophysical analyses suggested that both mutants affected in a distinct manner the structural integrity and plasticity of apoA-I that is necessary for normal functions. We conclude that the alteration of the hydrophobic 218-222 residues of apoA-I disrupts apoA-I/ABCA1 interactions and promotes the generation of defective pre-β particles that fail to mature into α-HDL subpopulations, thus resulting in low plasma apoA-I and HDL. Alterations of the charged 223, 226 residues caused milder but discrete changes in HDL phenotype.

Entities:  

Keywords:  LCAT; apolipoprotein A-I mutations; dyslipidemia; pre-β and α-HDL particles

Mesh:

Substances:

Year:  2013        PMID: 23990662      PMCID: PMC3826676          DOI: 10.1194/jlr.M038356

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

Review 1.  Cell cholesterol efflux: integration of old and new observations provides new insights.

Authors:  G H Rothblat; M de la Llera-Moya; V Atger; G Kellner-Weibel; D L Williams; M C Phillips
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

2.  Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo.

Authors:  Roshni R Singaraja; Miranda Van Eck; Nagat Bissada; Francesca Zimetti; Heidi L Collins; Reeni B Hildebrand; Anna Hayden; Liam R Brunham; Martin H Kang; Jean-Charles Fruchart; Theo J C Van Berkel; John S Parks; Bart Staels; George H Rothblat; Catherine Fiévet; Michael R Hayden
Journal:  Circulation       Date:  2006-08-28       Impact factor: 29.690

3.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

Authors:  Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

4.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

5.  Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.

Authors:  Angeliki Chroni; Adelina Duka; Horng-Yuan Kan; Tong Liu; Vassilis I Zannis
Journal:  Biochemistry       Date:  2005-11-01       Impact factor: 3.162

6.  Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.

Authors:  Ruth Frikke-Schmidt; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.

Authors:  Robert S Kiss; Nihan Kavaslar; Kei-ichiro Okuhira; Mason W Freeman; Stephanie Walter; Ross W Milne; Ruth McPherson; Yves L Marcel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

8.  Crystallization of truncated human apolipoprotein A-I in a novel conformation.

Authors:  D W Borhani; J A Engler; C G Brouillette
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-09

9.  Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.

Authors:  Angeliki Chroni; Horng-Yuan Kan; Adelina Shkodrani; Tong Liu; Vassilis I Zannis
Journal:  Biochemistry       Date:  2005-03-15       Impact factor: 3.162

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  3 in total

1.  Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Ioanna Tiniakou; Andreas K Kateifides; Christina Gkolfinopoulou; Angeliki Chroni; Efstratios Stratikos; Vassilis I Zannis; Dimitris Kardassis
Journal:  J Lipid Res       Date:  2013-10-12       Impact factor: 5.922

2.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

Review 3.  Structural Insights into High Density Lipoprotein: Old Models and New Facts.

Authors:  Valentin Gogonea
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.